Several therapeutic strategies inhibiting the inhibition of the uPA system have been or are being developed for suppression of tumor growth and progression, including anti-uPA antibodies, small molecular uPA inhibitors, cytotoxins targeting uPA/uPAR components, antisense therapy, and RNA interference technology [24,37-40]. The gene discussed is PLAU; the disease is neoplasm.